COA-Verified Research Peptides in Dubai & UAE
From AED 1,500 per pen · 3-pen and 5-pen bulk pricing available
What do you need next?
Three steps. No complexity.
Three receptors.
One compound.
Retatrutide is the only compound that activates all three metabolic receptors simultaneously. Where semaglutide targets one and tirzepatide targets two, retatrutide adds glucagon receptor co-activation — increasing energy expenditure in a way no approved therapy replicates. Developed by Eli Lilly as LY3437943, this triple-agonist represents a distinct class in peptide-based metabolic research, with Phase 3 clinical trial results now confirming efficacy beyond anything observed in approved GLP-1 or dual-agonist therapies. See the full head-to-head comparison.
Simultaneously
Activated
Third-Party Tested.
Verified Purity.
A Certificate of Analysis (COA) is an independent third-party lab report confirming peptide identity, purity, and absence of contaminants.
Every batch is independently tested by Janoshik Analytical — a leading third-party laboratory specialising in pharmaceutical purity analysis. Full test reports are included with every order.
- Format Prefilled Pen
- Total Volume 30mg Retatrutide
- Solution Stabilised · pH Balanced
- Pen Needles 31G · 5mm · Included
- Storage 2–8°C
- Purity ≥99.2% HPLC Verified
Box Contents
- 1× Prefilled Pen (30mg Retatrutide)
- 20× Pen Needles (5mm 31G)
- 1× Instruction Leaflet
- Certificate of Analysis (COA)
Click-controlled.
No measuring.
Unlike lyophilised powder formats requiring reconstitution, the Retatrutide Pen eliminates preparation variables entirely. The stabilised solution is pre-mixed, pH-balanced, and ready from the moment it arrives.
Customer Support
Every order includes direct access to our support team via WhatsApp for technical guidance, dose protocol questions, and storage recommendations. We respond within minutes, not hours. Whether you are selecting the right pen quantity for a research protocol or need guidance on cold-chain handling after delivery, our team provides personalised assistance from first enquiry through ongoing use. We also maintain a growing library of educational resources — including a dosage calculator, peptide storage guides, and comparative research articles — designed to support informed decision-making across every stage of peptide research.
What Our Clients Say
Feedback from researchers across Dubai and the UAE who use our retatrutide pens.
Meet GLOW
A three-compound research blend in a single lyophilised vial: 50mg GHK-Cu, 10mg BPC-157, and 10mg TB-500. Designed for researchers studying copper-peptide synergy, tissue-repair signalling, and recovery pathways. For Research Use Only.
Latest Research
Explore our peptide research library — in-depth articles covering protocols, clinical trials, and the latest data on next-generation research compounds. From triple-agonist peptides and GLP-1 receptor agonists to investigational oral drugs and dual-agonist obesity therapies, each article is grounded in published trial data and updated as new Phase 3 results emerge. Our coverage spans mechanism of action, dose-response data, regulatory approval timelines, and head-to-head compound comparisons.
Research Community
Remy Peptides is committed to advancing peptide-based research through open, evidence-driven education. Our research library provides free access to clinical trial analysis, comparative drug data, and regulatory updates covering the full landscape of metabolic research compounds — from injectable GLP-1 therapies and oral formulations to the emerging triple-agonist class. Every article is written with primary-source citations, updated as new Phase 3 results are published, and designed to help researchers, institutions, and independent investigators stay current with the latest developments in peptide science and drug development.
Ordering and Shipping
We accept card payments (secure link via WhatsApp), cash on delivery, and USDT cryptocurrency on the TRC-20 network. Orders placed before 4 PM ship same day across Dubai via insulated cold-chain packaging with temperature indicators to maintain peptide stability in transit. Abu Dhabi, Sharjah, and other emirates receive next-day delivery. Every shipment is tracked, and our team confirms dispatch via WhatsApp within minutes of order placement. For international orders of 100+ pens, we offer custom wholesale pricing with worldwide cold-chain fulfilment through our wholesale programme.
How Retatrutide Compares
| Feature | Retatrutide | Semaglutide | Tirzepatide |
|---|---|---|---|
| Receptor targets | GLP-1 + GIP + GCGR | GLP-1 only | GLP-1 + GIP |
| Mechanism class | Triple agonist | Single agonist | Dual agonist |
| Phase 3 weight reduction | 28.7% | ~15% | ~22.5% |
| Developer | Eli Lilly | Novo Nordisk | Eli Lilly |
| Glucagon pathway | Yes (unique) | No | No |
Sources: Eli Lilly TRIUMPH-4 (NCT05929066), SURMOUNT-1 (NCT04184622), STEP 1 (NCT03548935). For Research Use Only.